Huyabio International Is A Global Biopharmaceutical Company Based In San Diegocaliforniawith Additional Offices In Japansouth Koreacanadairelandand Various Locations In Chinathe Company Specializes In Accelerating The Development Of Novel Drug Candidates From Chinaaiming To Bridge These Innovations With Global Markets Huyabio Offers Comprehensive Drug Development Servicesincluding In Licensing And Co Development Of Preclinical And Clinical Stage Compoundsglobal Regulatory Strategiesand Partnership Models For Biopharma Companiesits Product Pipeline Includes Hbi 8000An Immuno Modulator Approved In Japan For Specific Types Of Leukemia And Lymphomaand Hbi 2376A Shp2 Inhibitor Targeting Solid Tumorsthe Company Collaborates With Notable Partners Such As Bristol Myers Squibb And Meiji Seika Pharma To Enhance Its Research And Development Efforts
